Search Results

Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

• Authors : Azam Salimi; Kema Marlen Schroeder; Mirle Schemionek-Reinders

Subjects: Autophagy; Multiple myeloma; Proteasome inhibition

• Source: BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)

Record details

The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism

• Authors : Pajonk, Frank; van Ophoven, Arndt; Weissenberger, Christian

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Prostate Cancer

• Source: BMC Cancer. 5(1)

Record details

Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells.

• Authors : Zhen-Xian Du¹ ; Hai-Yan Zhang² ; Xin Meng³

• Source: BMC Cancer. 2009, Vol. 9, Special section p1-11. 11p. 5 Graphs.

Record details

Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

• Authors : Azam, Salimi; Kema Marlen, Schroeder; Mirle, Schemionek-Reinders

Subjects: Proteasome Endopeptidase Complex; Pyrimidines; Pyridines

• Source: BMC cancer. 22(1)

Record details

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors.

• Source: BMC Cancer. 2011, Vol. 11 Issue 1, p485-493. 9p. 3 Diagrams, 1 Chart, 3 Graphs.

Record details

PSMD1 as a prognostic marker and potential target in oropharyngeal cancer

• Authors : Hae Chan Park; Hyojin Kim; Ji-Yeong Kim

Subjects: Head and neck cancer; Proteasome inhibitor; Targeted therapy

• Source: BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)

Record details

The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism

• Authors : Arndt van Ophoven; William H. McBride; Frank Pajonk

Subjects: Radiation-Sensitizing Agents; Cancer Research; Ionizing

• Source: BMC Cancer, Vol 5, Iss 1, p 76 (2005)BMC cancer, vol 5, iss 1BMC Cancer

Record details

Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.

• Authors : Park J; R&D Center, LG Life Sciences, Ltd, Daejeon, South Korea.; Park E

Subjects: Drug Synergism*; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*drug effects ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy

• Source: BMC cancer [BMC Cancer] 2016 Mar 24; Vol. 16, pp. 247. Date of Electronic Publication: 2016 Mar 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK.

• Authors : Salimi, Azam; Schroeder, Kema Marlen; Schemionek-Reinders, Mirle

• Source: BMC Cancer; 7/6/2022, Vol. 22 Issue 1, p1-10, 10p

Record details

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

• Authors : Haimei Tang; Xuefeng Huang; Da Wang

Subjects: Small interfering RNA; Programmed cell death; Cancer Research

• Source: BMC CancerBMC Cancer, Vol 11, Iss 1, p 485 (2011)

Record details